What is the treatment for Stevens-Johnson Syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Stevens-Johnson Syndrome

Patients with Stevens-Johnson Syndrome (SJS) should be immediately admitted to a burn center or intensive care unit with experience in managing SJS, with prompt discontinuation of the culprit drug and implementation of supportive care as the cornerstone of management. 1, 2

Initial Assessment and Management

  • Immediate actions:

    • Identify and discontinue the suspected causative drug 2
    • Calculate SCORTEN score to predict mortality risk 1
    • Transfer to burn center or ICU if >10% body surface area involvement 1
    • Consult dermatology for confirmation of diagnosis 1
  • Supportive care priorities:

    • Maintain barrier nursing in a side room with controlled humidity
    • Adjust ambient temperature to 25-28°C 1
    • Place patient on a pressure-relieving mattress 1
    • Establish fluid and electrolyte balance (requirements are lower than for thermal burns) 2

Wound Management

  • Skin care approach:

    • Handle skin carefully to minimize shearing forces and epidermal detachment 1
    • Apply bland emollients frequently to support barrier function 1
    • Use non-adherent dressings on denuded dermis 2
    • Consider silver-releasing antimicrobial dressings changed every 3 days 3
    • Leave detached epidermis in situ as a biological dressing 2
  • Wound cleaning:

    • Gently cleanse wounds using warmed sterile water, saline, or dilute chlorhexidine 2
    • Apply greasy emollient (50% white soft paraffin with 50% liquid paraffin) over entire epidermis 2

Systemic Therapy

  • Corticosteroids:

    • For immune checkpoint inhibitor-induced SJS: IV methylprednisolone 0.5-1 mg/kg, then convert to oral corticosteroids and taper over at least 4 weeks 1
    • For severe cases (≥10% BSA): IV methylprednisolone 1-2 mg/kg 1
    • Note: The traditional prohibition of corticosteroids in SJS is not relevant for immune-mediated cases 1
  • Additional therapies for severe or steroid-unresponsive cases:

    • Consider IVIG or cyclosporine A 1, 4
    • Recent evidence suggests early IVIG administration may improve outcomes 3

Management of Mucosal Surfaces

  • Ocular care:

    • Arrange ophthalmology consultation within 24 hours 2
    • Apply preservative-free lubricants every 2 hours 2
    • Consider topical antibiotics and corticosteroid drops under ophthalmologist supervision 2
    • Prevent corneal exposure in unconscious patients with moisture chambers 1
  • Oral care:

    • Clean mouth daily with warm saline mouthwashes 2
    • Consider topical corticosteroids (betamethasone sodium phosphate 0.5 mg in 10 mL water as rinse-and-spit) 1
    • Use benzydamine hydrochloride rinse every 3 hours, particularly before eating 2
  • Urogenital care:

    • Examine urogenital tract as part of initial assessment 1
    • Apply white soft paraffin to urogenital skin/mucosae every 4 hours 1
    • Use silicone dressings on eroded areas to reduce pain and prevent adhesions 1
    • Consider catheterization to prevent urethral strictures 1

Pain Management

  • Follow WHO analgesic ladder principles 2
  • Consider opiate-based regimens for moderate-to-severe pain 2
  • Patient-controlled analgesia may be beneficial 2

Prevention and Management of Complications

  • Infection prevention:

    • Avoid prophylactic systemic antibiotics 2
    • Monitor for signs of sepsis (leading cause of mortality) 4
    • Treat infections promptly when clinically indicated 2
  • Nutritional support:

    • Provide supplemental tube feeding as needed 3
    • Ensure adequate caloric intake to support healing 2

Follow-up Care

  • Provide written information about drugs to avoid 2
  • Arrange follow-up with dermatology, ophthalmology, and other specialists 2
  • Monitor for long-term sequelae including respiratory, ocular, cutaneous, and urogenital complications 2

Common Pitfalls to Avoid

  1. Delayed transfer to specialized care - Early transfer to burn centers is associated with improved outcomes 3
  2. Continued administration of culprit drug - Immediate discontinuation is essential 2
  3. Excessive fluid administration - SJS patients require less fluid than predicted by burn formulas 2
  4. Prophylactic antibiotics - May increase skin colonization with resistant organisms 1
  5. Aggressive debridement - Conservative wound management is preferred initially 1

The treatment approach should be multidisciplinary, involving dermatology, intensive care, ophthalmology, and specialist skincare nursing, with additional input from other specialties as needed based on organ involvement 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Stevens-Johnson Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.

Burns : journal of the International Society for Burn Injuries, 2017

Research

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Clinical reviews in allergy & immunology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.